|
1
|
López-Malo D, Villarón-Casares CA,
Alarcón-Jiménez J, Miranda M, Díaz-Llopis M, Romero FJ and Villar
VM: Curcumin as a Therapeutic Option in Retinal Diseases.
Antioxidants. 9(48)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Anand P, Kunnumakkara AB, Newman RA and
Aggarwal BB: Bioavailability of curcumin: Problems and promises.
Mol Pharm. 4:807–818. 2007.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Peddada KV, Brown A, Verma V and Nebbioso
M: Therapeutic potential of curcumin in major retinal pathologies.
Int Ophthalmol. 39:725–734. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Noorafshan A and Ashkani-Esfahani S: A
review of therapeutic effects of curcumin. Curr Pharm Des.
19:2032–2046. 2013.PubMed/NCBI
|
|
5
|
Deogade SC and Ghate S: Curcumin:
Therapeutic applications in systemic and oral health. Int J Biol
Pharm Res. 6:281–290. 2015.
|
|
6
|
Gupta SC, Kismali G and Aggarwal BB:
Curcumin, a component of turmeric: From farm to pharmacy.
Biofactors. 39:2–13. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lestari ML and Indrayanto G: Curcumin.
Profiles Drug Subst Excip Relat Methodol. 39:113–204.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mahady GB, Pendland SL, Yun G and Lu ZZ:
Turmeric (Curcuma longa) and curcumin inhibit the growth of
Helicobacter pylori, a group 1 carcinogen. Anticancer Res.
22:4179–4181. 2002.PubMed/NCBI
|
|
9
|
Reddy DNK, Huang FY, Wang SP and Kumar R:
Synergistic antioxidant and antibacterial activity of curcumin-C3
encapsulated chitosan nanoparticles. Curr Pharm Des. 26:5021–5029.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ammon HP and Wahl MA: Pharmacology of
Curcuma longa. Planta Med. 57:1–7. 1991.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Allegra A, Innao V, Russo S, Gerace D,
Alonci A and Musolino C: Anticancer activity of curcumin and its
analogues: preclinical and clinical studies. Cancer Invest.
35:1–22. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Muangnoi C, Ratnatilaka Na Bhuket P,
Jithavech P, Supasena W, Paraoan L, Patumraj S and Rojsitthisak P:
Curcumin diethyl disuccinate, a prodrug of curcumin, enhances
anti-proliferative effect of curcumin against HepG2 cells via
apoptosis induction. Sci Rep. 9(11718)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Priyadarsini KI: The chemistry of
curcumin: From extraction to therapeutic agent. Molecules.
19:20091–20112. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Guo LY, Cai XF, Lee JJ, Kang SS, Shin EM,
Zhou HY, Jung JW and Kim YS: Comparison of suppressive effects of
demethoxycurcumin and bisdemethoxycurcumin on expressions of
inflammatory mediators in vitro and in vivo. Arch Pharm Res.
31:490–496. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pescosolido N, Giannotti R, Plateroti AM,
Pascarella A and Nebbioso M: Curcumin: Therapeutical potential in
ophthalmology. Planta Med. 80:249–254. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Radomska-Leśniewska DM, Osiecka-Iwan A,
Hyc A, Góźdź A, Dąbrowska AM and Skopiński P: Therapeutic potential
of curcumin in eye diseases. Cent Eur J Immunol. 44:181–189.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shishodia S, Sethi G and Aggarwal BB:
Curcumin: Getting back to the roots. Ann N Y Acad Sci.
1056:206–217. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Singh S and Aggarwal BB: Activation of
transcription factor NF-kappa B is suppressed by curcumin
(diferuloylmethane) [corrected]. J Biol Chem. 270:24995–25000.
1995.PubMed/NCBI View Article : Google Scholar : Erratum in: J Biol
Chem 270, 30235, 1995.
|
|
19
|
Strimpakos AS and Sharma RA: Curcumin:
Preventive and therapeutic properties in laboratory studies and
clinical trials. Antioxid Redox Signal. 10:511–545. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang J, Xiong T, Zhou J, He H, Wu D, Du X,
Li X and Xu B: Enzymatic formation of curcumin in vitro and in
vivo. Nano Res. 11:3453–3461. 2018.
|
|
21
|
Chen T, Zhao L, Chen S, Zheng B, Chen H,
Zeng T, Sun H, Zhong S, Wu W, Lin X, et al: The curcumin analogue
WZ35 affects glycolysis inhibition of gastric cancer cells through
ROS-YAP-JNK pathway. Food Chem Toxicol. 137(111131)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang L, Wang C, Tao Z, Zhao L, Zhu Z, Wu
W, He Y, Chen H, Zheng B, Huang X, et al: Curcumin derivative WZ35
inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in
breast cancer. J Exp Clin Cancer Res. 38(460)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ohori H, Yamakoshi H, Tomizawa M, Shibuya
M, Kakudo Y, Takahashi A, Takahashi S, Kato S, Suzuki T, Ishioka C,
et al: Synthesis and biological analysis of new curcumin analogues
bearing an enhanced potential for the medicinal treatment of
cancer. Mol Cancer Ther. 5:2563–2571. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shoba G, Joy D, Joseph T, Majeed M,
Rajendran R and Srinivas PS: Influence of piperine on the
pharmacokinetics of curcumin in animals and human volunteers.
Planta Med. 64:353–356. 1998.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li M, Xin M, Guo C, Lin G and Wu X: New
nanomicelle curcumin formulation for ocular delivery: Improved
stability, solubility, and ocular anti-inflammatory treatment. Drug
Dev Ind Pharm. 43:1846–1857. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Barenholz Y: Doxil® - the first
FDA-approved nano-drug: Lessons learned. J Control Release.
160:117–134. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhang W, Ma W, Zhang J, Song X, Sun W and
Fan Y: The immunoregulatory activities of astragalus polysaccharide
liposome on macrophages and dendritic cells. Int J Biol Macromol.
105:852–861. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Cabral H and Kataoka K: Progress of
drug-loaded polymeric micelles into clinical studies. J Control
Release. 190:465–476. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sai N, Dong X, Huang P, You L, Yang C, Liu
Y, Wang W, Wu H, Yu Y, Du Y, et al: A novel gel-forming solution
based on PEG-DSPE/Solutol HS 15 mixed micelles and Gellan gum for
ophthalmic delivery of curcumin. Molecules. 25(25)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen Y, Lu Y, Lee RJ and Xiang G: Nano
encapsulated curcumin: and its potential for biomedical
applications. Int J Nanomedicine. 15:3099–3120. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang J, Sun H, Zhou N, Zhang B and Ma J:
Preparation and evaluation of biodegradable scleral plug containing
curcumin in rabbit eye. Curr Eye Res. 42:1597–1603. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Mazzolani F, Togni S, Giacomelli L,
Eggenhoffner R and Franceschi F: Oral administration of a
curcumin-phospholipid formulation (Meriva®) for
treatment of chronic diabetic macular edema: A pilot study. Eur Rev
Med Pharmacol Sci. 22:3617–3625. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Steigerwalt R, Nebbioso M, Appendino G,
Belcaro G, Ciammaichella G, Cornelli U, Luzzi R, Togni S, Dugall M,
Cesarone MR, et al: Meriva®, a lecithinized curcumin
delivery system, in diabetic microangiopathy and retinopathy.
Panminerva Med. 54 (Suppl 4):11–16. 2012.PubMed/NCBI
|
|
34
|
Lal B, Kapoor AK, Asthana OP, Agrawal PK,
Prasad R, Kumar P and Srimal RC: Efficacy of curcumin in the
management of chronic anterior uveitis. Phytother Res. 13:318–322.
1999.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Wang LL, Sun Y, Huang K and Zheng L:
Curcumin, a potential therapeutic candidate for retinal diseases.
Mol Nutr Food Res. 57:1557–1568. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bucolo C, Drago F, Maisto R, Romano GL,
D'Agata V, Maugeri G and Giunta S: Curcumin prevents high glucose
damage in retinal pigment epithelial cells through ERK1/2-mediated
activation of the Nrf2/HO-1 pathway. J Cell Physiol.
234:17295–17304. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Pittalà V, Fidilio A, Lazzara F, Platania
CBM, Salerno L, Foresti R, Drago F and Bucolo C: Effects of novel
nitric oxide-releasing molecules against oxidative stress on
retinal pigmented epithelial cells. Oxid Med Cell Longev.
2017(1420892)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yonekawa Y, Miller JW and Kim IK:
Age-related macular degeneration: advances in management and
diagnosis. J Clin Med. 4:343–359. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ulańczyk Z, Grabowicz A, Cecerska-Heryć E,
Śleboda-Taront D, Krytkowska E, Mozolewska-Piotrowska K, Safranow
K, Kawa MP, Dołęgowska B and Machalińska A: Dietary and lifestyle
factors modulate the activity of the endogenous antioxidant system
in patients with age-related macular degeneration: correlations
with disease severity. Antioxidants. 9(9)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Muangnoi C, Sharif U, Ratnatilaka Na
Bhuket P, Rojsitthisak P and Paraoan L: Protective effects of
curcumin ester prodrug, curcumin diethyl disuccinate against
H2O2-induced oxidative stress in human
retinal pigment epithelial cells: potential therapeutic avenues for
age-related macular degeneration. Int J Mol Sci.
20(20)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yau JW, Rogers SL, Kawasaki R, Lamoureux
EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund
J, et al: Meta-Analysis for Eye Disease (META-EYE) Study Group:
Global prevalence and major risk factors of diabetic retinopathy.
Diabetes Care. 35:556–564. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Antonetti DA, Klein R and Gardner TW:
Diabetic retinopathy. N Engl J Med. 366:1227–1239. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Platania CBM, Fidilio A, Lazzara F, Piazza
C, Geraci F, Giurdanella G, Leggio GM, Salomone S, Drago F and
Bucolo C: Retinal protection and distribution of curcumin in vitro
and in vivo. Front Pharmacol. 9(670)2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Roy S, Maiello M and Lorenzi M: Increased
expression of basement membrane collagen in human diabetic
retinopathy. J Clin Invest. 93:438–442. 1994.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Barber AJ: Diabetic retinopathy: Recent
advances towards understanding neurodegeneration and vision loss.
Sci China Life Sci. 58:541–549. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wan TT, Li XF, Sun YM, Li YB and Su Y:
Recent advances in understanding the biochemical and molecular
mechanism of diabetic retinopathy. Biomed Pharmacother. 74:145–147.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Wu Y, Tang L and Chen B: Oxidative stress:
Implications for the development of diabetic retinopathy and
antioxidant therapeutic perspectives. Oxid Med Cell Longev.
2014(752387)2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Aiello LP, Pierce EA, Foley ED, Takagi H,
Chen H, Riddle L, Ferrara N, King GL and Smith LE: Suppression of
retinal neovascularization in vivo by inhibition of vascular
endothelial growth factor (VEGF) using soluble VEGF-receptor
chimeric proteins. Proc Natl Acad Sci USA. 92:10457–10461.
1995.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Limb GA, Soomro H, Janikoun S, Hollifield
RD and Shilling J: Evidence for control of tumour necrosis
factor-alpha (TNF-alpha) activity by TNF receptors in patients with
proliferative diabetic retinopathy. Clin Exp Immunol. 115:409–414.
1999.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Gupta SK, Kumar B, Nag TC, Agrawal SS,
Agrawal R, Agrawal P, Saxena R and Srivastava S: Curcumin prevents
experimental diabetic retinopathy in rats through its hypoglycemic,
antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol
Ther. 27:123–130. 2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Khimmaktong W, Petpiboolthai H, Sriya P
and Anupunpisit V: Effects of curcumin on restoration and
improvement of microvasculature characteristic in diabetic rat's
choroid of eye. J Med Assoc Thai. 97 (Suppl 2):S39–S46.
2014.PubMed/NCBI
|
|
52
|
Ren YX, Ma JX, Zhao F, An JB, Geng YX and
Liu LY: Effects of Curcumin on Epidermal Growth Factor in
Proliferative Vitreoretinopathy. Cell Physiol Biochem.
47:2136–2146. 2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Wang L, Li C, Guo H, Kern TS, Huang K and
Zheng L: Curcumin inhibits neuronal and vascular degeneration in
retina after ischemia and reperfusion injury. PLoS One.
6(e23194)2011.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Wang S, Ye Q, Tu J, Zhang M and Ji B:
Curcumin protects against hypertension aggravated retinal
ischemia/reperfusion in a rat stroke model. Clin Exp Hypertens.
39:711–717. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Limoli PG, Vingolo EM, Limoli C and
Nebbioso M: stem cell surgery and growth factors in retinitis
pigmentosa patients: Pilot study after literature review.
Biomedicines. 7(7)2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Vasireddy V, Chavali VR, Joseph VT, Kadam
R, Lin JH, Jamison JA, Kompella UB, Reddy GB and Ayyagari R: Rescue
of photoreceptor degeneration by curcumin in transgenic rats with
P23H rhodopsin mutation. PLoS One. 6(e21193)2011.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Emoto Y, Yoshizawa K, Uehara N, Kinoshita
Y, Yuri T, Shikata N and Tsubura A: Curcumin suppresses
N-methyl-N-nitrosourea-induced photoreceptor apoptosis in
Sprague-Dawley rats. In Vivo. 27:583–590. 2013.PubMed/NCBI
|
|
58
|
Li Y, Sun W, Han N, Zou Y and Yin D:
Curcumin inhibits proliferation, migration, invasion and promotes
apoptosis of retinoblastoma cell lines through modulation of
miR-99a and JAK/STAT pathway. BMC Cancer. 18(1230)2018.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Bar-Sela G, Epelbaum R and Schaffer M:
Curcumin as an anti-cancer agent: Review of the gap between basic
and clinical applications. Curr Med Chem. 17:190–197.
2010.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Burlacu A, Genovesi S, Popa IV and
Crisan-Dabija R: Unpuzzling COVID-19 prothrombotic state: are
preexisting thrombophilic risk profiles responsible for
heterogenous thrombotic events? Clin Appl Thromb Hemost.
26(1076029620952884)2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Moghadamtousi SZ, Kadir HA, Hassandarvish
P, Tajik H, Abubakar S and Zandi K: A review on antibacterial,
antiviral, and antifungal activity of curcumin. Biomed Res Int.
2014(186864)2014.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Praditya D, Kirchhoff L, Brüning J,
Rachmawati H, Steinmann J and Steinmann E: Anti-infective
properties of the golden spice curcumin. Front Microbiol.
10(912)2019.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Taurone S, Ripandelli G, Pacella E,
Bianchi E, Plateroti AM, De Vito S, Plateroti P, Grippaudo FR,
Cavallotti C and Artico M: Potential regulatory molecules in the
human trabecular meshwork of patients with glaucoma:
Immunohistochemical profile of a number of inflammatory cytokines.
Mol Med Rep. 11:1384–1390. 2015.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Stanton CM and Wright AF: Inflammatory
biomarkers for AMD. Adv Exp Med Biol. 801:251–257. 2014.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Abcouwer SF: Angiogenic factors and
cytokinesin diabetic retinopathy. J Clin Cell Immunol Suppl.
1:1–12. 2013.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Chua J, Vania M, Cheung CM, Ang M, Chee
SP, Yang H, Li J and Wong TT: Expression profile of inflammatory
cytokines in aqueous from glaucomatous eyes. Mol Vis. 18:431–438.
2012.PubMed/NCBI
|
|
67
|
Bianchi E, Ripandelli G, Feher J,
Plateroti AM, Plateroti R, Kovacs I, Plateroti P, Taurone S and
Artico M: Occlusion of retinal capillaries caused by glial cell
proliferation in chronic ocular inflammation. Folia Morphol
(Warsz). 74:33–41. 2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Taurone S, Ralli M, Nebbioso M, Greco A,
Artico M, Attanasio G, Gharbiya M, Plateroti AM, Zamai L and Micera
A: The role of inflammation in diabetic retinopathy: A review. Eur
Rev Med Pharmacol Sci. 24:10319–10329. 2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Aggarwal BB and Harikumar KB: Potential
therapeutic effects of curcumin, the anti-inflammatory agent,
against neurodegenerative, cardiovascular, pulmonary, metabolic,
autoimmune and neoplastic diseases. Int J Biochem Cell Biol.
41:40–59. 2009.PubMed/NCBI View Article : Google Scholar
|
